Pfizer (PFE), BioTech (BNTX) Report Complete Patient Dosing in First Cohort of Ph. 1/2 Trial of COVID-19 vaccine candidates in Germany
Go back to Pfizer (PFE), BioTech (BNTX) Report Complete Patient Dosing in First Cohort of Ph. 1/2 Trial of COVID-19 vaccine candidates in Germany| (NASDAQ: BNTX) | Delayed: 90.79 +0.60 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.19 | 52 Week High | $ | |||
| Open | $90.39 | 52 Week Low | $ | |||
| Day High | $91.71 | P/E | N/A | |||
| Day Low | $90.14 | EPS | $ | |||
| Volume | 89,377 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.87 -0.21 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $24.99 | 52 Week Low | $28.25 | |||
| Day High | $25.24 | P/E | 15.07 | |||
| Day Low | $24.78 | EPS | $1.65 | |||
| Volume | 20,234,586 | |||||

